Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$1.27M
20.86K shares
What this filing means
ROBIN HOWARD W plans to sell 20.86K shares of NEKTAR THERAPEUTICS valued at approximately $1.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001959173-26-006164
DirectorOfficer· President & CEO
Since Aug 2018
20.86K
Shares to sell
$1.27M
Approx. market value
418.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/14/2026
418.00Total acquired418.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/14/2026 | Restricted Stock Vesting Compensation | 418.00 | — |
| Total | 418.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
10K
Market value
$611.9K
6/17/2026
—Completed
Units to sell
10K
Market value
$603.1K
6/16/2026
—Completed
Units to sell
444.00
Market value
$29.1K
5/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
418.00
Market value
$30.1K
8/18/2026
Total
Units
20.86K
Value
$1.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2026 | 10K | $611.9K | — | Completed |
6/16/2026 | 10K | $603.1K | — | Completed |
5/19/2026 | 444.00 | $29.1K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 418.00 | $30.1K | NASDAQ | Planned |
| Total | 20.86K | $1.27M | ||